Announcement on Shareholding Reduction Plan of Shareholder
Filed with SSE · · 7 pages · Chinese
Summary by 6ix AI
Shanghai MicuRx Pharmaceutical Co., Ltd. has announced a shareholding reduction plan by its shareholders, Best Idea International Limited, JSR Limited, and GP TMT Holdings Limited. The plan involves the shareholders reducing their holdings through market transactions, with specific limits on the number of shares to be sold. The reduction is primarily driven by the shareholders' funding needs and will be executed at market prices, with adjustments for any corporate actions during the reduction period. The filing also outlines potential risks associated with the reduction plan, including uncertainties regarding its implementation and the possibility of changes in control of the company.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai MicuRx Pharmaceutical Co., Ltd. on 6ix
Earlier from Shanghai MicuRx Pharmaceutical
- Announcement on Expiration of Shareholding Reduction Plan by Shareholder and Results of Shareholding Reduction
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
- Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
- Announcement on Continued Use of Idle Raised Funds for Cash Management
- Announcement on Resignation of Securities Affairs Representative
Later from Shanghai MicuRx Pharmaceutical
- Announcement on Progress of Litigation Involving a U.S. Subsidiary
- (688373)"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 30th Meeting of the 2nd Board of Directors
- (688373)"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Announcement on Signing of Authorization and License Agreement with ClearideBio
- (688373)"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 31st Meeting of the 2nd Board of Directors
- (688373)"SHANGHAI MICURX PHARMACEUTICAL CO., LTD."Report for Q3 2026
Follow Shanghai MicuRx Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai MicuRx Pharmaceutical